GTBP   $2.29  8.53% Market Closed After Close 2.35 2.62%

GT Biopharma Inc
Total Cash 9.25M
totalCashPerShare 4.139
EBITDA
Total Debt 0.00
quickRatio 2.46
currentRatio 2.465
Total Revenue
debtToEquity
Revenue/Share
ROA -0.60592
ROE -1.31481
grossProfits
freeCashflow -8.04M
operatingCashflow -11.71M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -4.80M
forwardPE
floatShares 1.79M
sharesOutstanding 2.23M
sharesShort 5.02K
sharesShortPriorMonth 9.28K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.60%
Short Ratio help_outline 0.43%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 2.465
Price To Book help_outline 0.81
earningsQuarterlyGrowth
netIncomeToCommon -11.35M
trailingEps -7.76%
forwardEps -10.80%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2024
institutionsCount 23
lastUpdated Oct. 16, 2024, 11:49 p.m.